Indication
Anal Neoplasm
2 clinical trials
3 products
Product
Vobramitamab DuocarmazineClinical trial
A Phase 2, Open-label, Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration-resistant Prostate Cancer and Other Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2027-05-01
Product
VobramitamabClinical trial
A Phase 2, Open Label, Study of VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL), (AIN2, AIN3, PAIN2, PAIN3) in Individuals That Are Seronegative for Human Immunodeficiency Virus (HIV)-1/2Status: Completed, Estimated PCD: 2020-06-16
Product
VGX-3100